NewAmsterdam Pharma Company NVNASDAQ:NAMS
- LAST PRICE18.7500
- TODAY'S CHANGE (%)0.2300 (1.2419%)
- Bid / Lots17.8300/ 1
- Ask / Lots19.8300/ 1
- Open / Previous Close18.6700 / 18.5200
- Day Range
- 52 Week Range
- Volume547,724
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NAMS |
|---|---|---|
| 09:32 ET | 6038 | 18.8 |
| 09:34 ET | 200 | 18.71 |
| 09:38 ET | 500 | 18.64 |
| 09:39 ET | 896 | 18.79 |
| 09:41 ET | 100 | 18.79 |
| 09:43 ET | 300 | 18.755 |
| 09:45 ET | 100 | 18.755 |
| 09:48 ET | 100 | 18.755 |
| 09:50 ET | 200 | 18.885 |
| 09:54 ET | 800 | 18.7 |
| 09:57 ET | 600 | 18.795 |
| 09:59 ET | 500 | 18.785 |
| 10:01 ET | 100 | 18.845 |
| 10:03 ET | 100 | 18.71 |
| 10:08 ET | 607 | 18.815 |
| 10:10 ET | 400 | 18.75 |
| 10:12 ET | 952 | 18.84 |
| 10:14 ET | 100 | 18.8 |
| 10:15 ET | 100 | 18.79 |
| 10:19 ET | 400 | 18.88 |
| 10:21 ET | 100 | 18.79 |
| 10:24 ET | 400 | 18.8 |
| 10:26 ET | 100 | 18.855 |
| 10:28 ET | 11088 | 18.79 |
| 10:30 ET | 300 | 18.79 |
| 10:32 ET | 200 | 18.785 |
| 10:37 ET | 200 | 18.65 |
| 10:42 ET | 500 | 18.52 |
| 10:46 ET | 100 | 18.49 |
| 10:48 ET | 126 | 18.495 |
| 10:51 ET | 2773 | 18.44 |
| 10:53 ET | 2687 | 18.28 |
| 10:57 ET | 100 | 18.24 |
| 11:02 ET | 100 | 18.26 |
| 11:08 ET | 411 | 18.41 |
| 11:09 ET | 274 | 18.375 |
| 11:13 ET | 2939 | 18.38 |
| 11:15 ET | 4400 | 18.25 |
| 11:18 ET | 950 | 18.275 |
| 11:20 ET | 1139 | 18.265 |
| 11:26 ET | 600 | 18.38 |
| 11:29 ET | 511 | 18.31 |
| 11:31 ET | 118 | 18.345 |
| 11:38 ET | 100 | 18.26 |
| 11:42 ET | 100 | 18.285 |
| 11:44 ET | 100 | 18.285 |
| 11:49 ET | 294 | 18.295 |
| 11:51 ET | 601 | 18.38 |
| 12:02 ET | 4239 | 18.38 |
| 12:14 ET | 100 | 18.37 |
| 12:16 ET | 200 | 18.41 |
| 12:21 ET | 200 | 18.38 |
| 12:30 ET | 500 | 18.38 |
| 01:01 ET | 100 | 18.385 |
| 01:03 ET | 700 | 18.375 |
| 01:06 ET | 139 | 18.405 |
| 01:10 ET | 106 | 18.405 |
| 01:15 ET | 3100 | 18.4383 |
| 01:24 ET | 100 | 18.33 |
| 01:26 ET | 300 | 18.37 |
| 01:28 ET | 100 | 18.37 |
| 01:30 ET | 1100 | 18.41 |
| 01:32 ET | 745 | 18.52 |
| 01:33 ET | 1939 | 18.49 |
| 01:42 ET | 107 | 18.43 |
| 01:50 ET | 100 | 18.31 |
| 01:53 ET | 100 | 18.31 |
| 01:57 ET | 200 | 18.39 |
| 02:04 ET | 100 | 18.29 |
| 02:06 ET | 100 | 18.24 |
| 02:09 ET | 100 | 18.23 |
| 02:13 ET | 1100 | 18.245 |
| 02:15 ET | 200 | 18.245 |
| 02:22 ET | 400 | 18.24 |
| 02:31 ET | 100 | 18.18 |
| 02:33 ET | 200 | 18.16 |
| 02:38 ET | 930 | 18.21 |
| 02:40 ET | 100 | 18.16 |
| 02:42 ET | 997 | 18.2294 |
| 02:44 ET | 200 | 18.205 |
| 02:45 ET | 100 | 18.2 |
| 02:51 ET | 748 | 18.15 |
| 02:54 ET | 1400 | 18.24 |
| 02:56 ET | 100 | 18.31 |
| 02:58 ET | 100 | 18.31 |
| 03:00 ET | 777 | 18.215 |
| 03:03 ET | 700 | 18.23 |
| 03:05 ET | 748 | 18.275 |
| 03:07 ET | 1292 | 18.38 |
| 03:09 ET | 800 | 18.25 |
| 03:12 ET | 800 | 18.26 |
| 03:18 ET | 420 | 18.235 |
| 03:20 ET | 100 | 18.195 |
| 03:21 ET | 1500 | 18.37 |
| 03:23 ET | 2000 | 18.515 |
| 03:25 ET | 934 | 18.56 |
| 03:30 ET | 500 | 18.585 |
| 03:32 ET | 100 | 18.64 |
| 03:34 ET | 400 | 18.6 |
| 03:38 ET | 1300 | 18.61 |
| 03:41 ET | 300 | 18.58 |
| 03:45 ET | 800 | 18.5 |
| 03:48 ET | 333 | 18.525 |
| 03:50 ET | 100 | 18.5 |
| 03:52 ET | 1421 | 18.5 |
| 03:54 ET | 100 | 18.5 |
| 03:56 ET | 7260 | 18.69 |
| 03:57 ET | 7578 | 18.775 |
| 03:59 ET | 305103 | 18.75 |
May 29, 2024
NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in June, from 8:00AM ET on Wednesday May 29, 2024 by Dow Jones
8:00AM ET on Wednesday May 29, 2024 by Dow Jones
May 21, 2024
May 15, 2024
DJ NewAmsterdam Pharma Initiated at Buy by TD Cowen, from 1:21PM ET on Wednesday May 15, 2024 by Dow Jones
1:21PM ET on Wednesday May 15, 2024 by Dow Jones
May 9, 2024
Press Release: NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results, from 8:00AM ET on Thursday May 09, 2024 by Dow Jones
8:00AM ET on Thursday May 09, 2024 by Dow JonesNewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results, from 8:00AM ET on Thursday May 09, 2024 by Dow Jones
8:00AM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
NewAmsterdam Pharma Company NV | 1.7B | -6.9x | --- |
Keros Therapeutics Inc | 1.7B | -9.1x | --- |
Sana Biotechnology Inc | 1.7B | -4.9x | --- |
Syndax Pharmaceuticals Inc | 1.6B | -6.0x | --- |
Spyre Therapeutics Inc | 1.8B | -0.5x | --- |
Edgewise Therapeutics Inc | 1.6B | -11.2x | --- |
Company Information
NewAmsterdam Pharma Company NV is a Netherlands based company. NewAmsterdam Pharma operates as a clinical-stage company and focuses on the research and development of transformative oral therapies for major cardiometabolic diseases. The Company is investigating obicetrapib, an oral, low-dose and once-daily, cholesteryl ester transfer protein (CETP) inhibitor, as the low-density lipoprotein cholesterol (LDL-C) lowering therapy to be used as an adjunct statin therapy for high-risk cardiovascular disease (CVD) patients. The Company is also testing obicetrapib as a fixed-dose combination therapy with ezetimibe in a secondary Phase 2 trial, ROSE2, for other diseases such as Alzheimer’s disease. The Company strives to offer its products around the world.
Contact Information
- Headquarters
- Gooimeer 2-35NAARDEN, Netherlands 1411 DC
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- William Lewis
- Chief Executive Officer, Executive Director
- Michael Davidson
- Interim Chief Financial Officer
- Louise Kooij
- Chief Operating Officer
- Douglas Kling
- Chief Scientific Officer, Non-Executive Director
- John Kastelein
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.7B |
|---|---|
Revenue (TTM) | $6.9M |
Shares Outstanding | 90.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.70 |
Book Value | $3.50 |
P/E Ratio | -6.9x |
Price/Sales (TTM) | 245.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,894.14% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
